quiet!, page-3

incorrect, there will be plenty of news to keep punters interested over the next few weeks.
OBJ is the most rediculously undervauled stock around considering 1. it works 2. already in bed with cosmetic company(who wouldn,t sign their name to something that messes with peoples skin if it did'nt work)3 major pharmaceutical j/v on the way, imagine if OBJ gets into bed with one of their directors ex employees, ie Merck, Novartis, 3M,
if/when that happens, this stock will be rerated. Look at POH, phosphagenics, transdermal delivery of morphine, alters the drug= huge lead times to the mkt=yet still has $150m mkt cap.....OBJ=no re approval of drugs as no alteration to compound= mkt cap of $10m,